Back
ABN AMRO Bank NV Vs. SpringWorks Therapeutics Industry Stock Comparison
Buy
73
AAVMY
ABN AMRO Bank NV
Last Price:
$23.70
Seasonality Move:
10.99%
Sell
27
SWTX
SpringWorks Therapeutics
Last Price:
$46.10
Seasonality Move:
-1.98%
Buy
73
ABN AMRO Bank NV (AAVMY)
is a Buy
Is ABN AMRO Bank NV a Buy, Sell or Hold?
-
The current ABN AMRO Bank NV [AAVMY] share price is $23.70. The Score for AAVMY is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
AAVMY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
-
The current SpringWorks Therapeutics [SWTX] share price is $46.11. The Score for SWTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
SWTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AAVMY Stock Price Chart
What is ABN AMRO Bank NV's stock price today?
-
The ABN AMRO Bank NV share price today is $23.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AAVMY is experiencing slight buying pressure.
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $46.11The current trend is moderately bullish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.
AAVMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.73 | Buy |
Relative Strength Index (14 RSI): | 76.39 | Buy |
Chaikin Money Flow: | 1365 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.31 - 22.29) | Buy |
Bollinger Bands (100): | (16.49 - 21.37) | Buy |
SWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.86 | Buy |
Relative Strength Index (14 RSI): | 57.85 | Buy |
Chaikin Money Flow: | -4860653 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.78 - 47.3) | Buy |
Bollinger Bands (100): | (36.63 - 51.11) | Buy |
AAVMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.39 | Buy |
20-day SMA: | 21.57 | Buy |
50-day SMA: | 21.05 | Buy |
200-day SMA: | 17.8 | Buy |
8-day EMA: | 22.65 | Buy |
20-day EMA: | 21.8 | Buy |
50-day EMA: | 20.77 | Buy |
200-day EMA: | 18.37 | Buy |
SWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.18 | Sell |
20-day SMA: | 45.07 | Buy |
50-day SMA: | 44.77 | Buy |
200-day SMA: | 39.82 | Buy |
8-day EMA: | 46.05 | Buy |
20-day EMA: | 45.12 | Buy |
50-day EMA: | 44.61 | Buy |
200-day EMA: | 41.64 | Buy |
ABN AMRO Bank NV Earnings Growth & AAVMY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $3.01 per share.
ABN AMRO Bank NV Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
SpringWorks Therapeutics Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |